Determination of dopamine and dopamine-derived (R)-/(S)-salsolinol and norsalsolinol in various human brain areas using solid-phase extraction and gas chromatography/mass spectrometry

被引:80
作者
Musshoff, F
Schmidt, P
Dettmeyer, R
Priemer, F
Jachau, K
Madea, B
机构
[1] Univ Bonn, Inst Legal Med, D-53111 Bonn, Germany
[2] Univ Munich, Inst Legal Med, D-80337 Munich, Germany
[3] Otto von Guericke Univ, Inst Legal Med, D-39120 Magdeburg, Germany
关键词
dopamine; salsolinol; norsalsolinol; enantiomeric composition; brain; human; GC/MS analysis;
D O I
10.1016/S0379-0738(00)00225-5
中图分类号
DF [法律]; D9 [法律]; R [医药、卫生];
学科分类号
0301 ; 10 ;
摘要
Using a solid-phase extraction procedure and a gas chromatographic-mass spectrometric (GC/MS) method the levels of dopamine and the levels of dopamine-derived salsolinol (SAL) and norsalsolinol (NorSAL) were determined in human brain areas involved in the etiology of alcoholism, parkinsonism and other diseases. The possibility that biosynthesis of salsolinol occurs through a stereospecific enzymatic reaction was considered. Using a two-step derivatization with N-methyl-N-trimethylsilyltrifluoracetamido (MSTFA) and the chiral reagent (R)-(-)-2-phenylbutyryl chloride, baseline separated peaks of (R)- and (S)-SAL were obtained. Both enantiomers were found in human brain samples with no correlations between levels of salsolinol and dopamine. These findings do not support the hypothesis that only an enantio-selective synthesis of (R)-SAL by a putative salsolinol synthase is responsible for the in vivo formation. In our opinion, non-enzymatic formation of salsolinol via the Pictet-Spengler reaction reveals both salsolinol enantiomers and an additional enzymatic synthesis of only (R)-SAL explains the enantiomer ratio (R)-/(S)-SAL of approximately 2. (C) 2000 Elsevier Science Ireland Ltd. All rights reserved.
引用
收藏
页码:359 / 366
页数:8
相关论文
共 30 条
[11]   A dopaminergic neurotoxin, (R)-N-methylsalsolinol, increases in parkinsonian cerebrospinal fluid [J].
Maruyama, W ;
Abe, T ;
Tohgi, H ;
Dostert, P ;
Naoi, M .
ANNALS OF NEUROLOGY, 1996, 40 (01) :119-122
[12]   A dopaminergic neurotoxin, 1(R),2(N)-dimethyl-6,7-dihydroxy-1,2,3,4-tetrahydroisoquinoline, N-methyl(R)salsolinol, and its oxidation product, 1,2(N)-dimethyl-6,7-dihydroxyisoquinolinium ion, accumulate in the nigrostriatal system of the human brain [J].
Maruyama, W ;
Sobue, G ;
Matsubara, K ;
Hashizume, Y ;
Dostert, P ;
Naoi, M .
NEUROSCIENCE LETTERS, 1997, 223 (01) :61-64
[13]   N-METHYL(R)SALSOLINOL PRODUCES HYDROXYL RADICALS - INVOLVEMENT TO NEUROTOXICITY [J].
MARUYAMA, W ;
DOSTERT, P ;
MATSUBARA, K ;
NAOI, M .
FREE RADICAL BIOLOGY AND MEDICINE, 1995, 19 (01) :67-75
[14]   Stereospecific occurrence of a parkinsonism-inducing catechol isoquinoline, N-methyl(R)salsolinol, in the human intraventricular fluid [J].
Maruyama, W ;
Narabayashi, H ;
Dostert, P ;
Naoi, M .
JOURNAL OF NEURAL TRANSMISSION, 1996, 103 (8-9) :1069-1076
[15]   NEUROAMINE-DERIVED ALKALOIDS - SUBSTRATE-PREFERRED INHIBITORS OF RAT-BRAIN MONOAMINE-OXIDASE INVITRO [J].
MEYERSON, LR ;
MCMURTREY, KD ;
DAVIS, VE .
BIOCHEMICAL PHARMACOLOGY, 1976, 25 (09) :1013-1020
[16]   INHIBITION OF TYROSINE-HYDROXYLASE BY R AND S ENANTIOMERS OF SALSOLINOL, 1-METHYL-6,7-DIHYDROXY-1,2,3,4-TETRAHYDROISOQUINOLINE [J].
MINAMI, M ;
TAKAHASHI, T ;
MARUYAMA, W ;
TAKAHASHI, A ;
DOSTERT, P ;
NAGATSU, T ;
NAOI, M .
JOURNAL OF NEUROCHEMISTRY, 1992, 58 (06) :2097-2101
[17]  
Müller T, 1999, MOVEMENT DISORD, V14, P514, DOI 10.1002/1531-8257(199905)14:3<514::AID-MDS1023>3.0.CO
[18]  
2-2
[19]   A systematic regional study of dopamine and dopamine-derived salsolinol and norsalsolinol levels in human brain areas [J].
Musshoff, F ;
Schmidt, P ;
Dettmeyer, R ;
Priemer, F ;
Wittig, H ;
Madea, B .
FORENSIC SCIENCE INTERNATIONAL, 1999, 105 (01) :1-11
[20]   DIFFERENTIAL ACTIONS ON VOLUNTARY ALCOHOL INTAKE OF TETRAHYDROISOQUINOLINES OR A BETA-CARBOLINE INFUSED CHRONICALLY IN VENTRICLE OF RAT [J].
MYERS, RD ;
MELCHIOR, CL .
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1977, 7 (04) :381-392